ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 173 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $379,000 | +28.5% | 549,367 | -4.1% | 0.00% | – |
Q3 2020 | $295,000 | -32.2% | 573,061 | -3.2% | 0.00% | – |
Q2 2020 | $435,000 | -52.6% | 592,005 | -39.9% | 0.00% | – |
Q1 2020 | $918,000 | +6.4% | 984,266 | +132.7% | 0.00% | – |
Q4 2019 | $863,000 | -17.4% | 422,985 | +16.2% | 0.00% | – |
Q3 2019 | $1,045,000 | -59.3% | 364,096 | +8.9% | 0.00% | -100.0% |
Q2 2019 | $2,565,000 | -52.5% | 334,456 | -17.7% | 0.00% | -50.0% |
Q1 2019 | $5,399,000 | -77.6% | 406,228 | -73.7% | 0.00% | -77.8% |
Q4 2018 | $24,104,000 | -19.1% | 1,547,069 | +2.0% | 0.01% | 0.0% |
Q3 2018 | $29,794,000 | -20.7% | 1,516,226 | +15.8% | 0.01% | -25.0% |
Q2 2018 | $37,570,000 | +548.4% | 1,309,058 | +434.4% | 0.01% | +500.0% |
Q1 2018 | $5,794,000 | -79.4% | 244,972 | -81.3% | 0.00% | -80.0% |
Q4 2017 | $28,087,000 | -6.2% | 1,309,443 | +3.4% | 0.01% | -9.1% |
Q3 2017 | $29,948,000 | +168.7% | 1,266,289 | +123.8% | 0.01% | +266.7% |
Q2 2017 | $11,145,000 | +30.1% | 565,719 | +38.7% | 0.00% | 0.0% |
Q1 2017 | $8,565,000 | +251.7% | 407,850 | +215.0% | 0.00% | +200.0% |
Q4 2016 | $2,435,000 | -72.3% | 129,476 | -69.3% | 0.00% | -66.7% |
Q3 2016 | $8,800,000 | -13.4% | 421,417 | +5.7% | 0.00% | -25.0% |
Q2 2016 | $10,164,000 | +9.4% | 398,517 | +13.5% | 0.00% | 0.0% |
Q1 2016 | $9,287,000 | -52.8% | 351,117 | -23.7% | 0.00% | -50.0% |
Q4 2015 | $19,687,000 | +30.2% | 460,192 | -19.3% | 0.01% | +33.3% |
Q3 2015 | $15,115,000 | -27.0% | 570,139 | -8.2% | 0.01% | -25.0% |
Q2 2015 | $20,694,000 | +9.3% | 620,882 | +9.1% | 0.01% | +14.3% |
Q1 2015 | $18,931,000 | -2.1% | 568,836 | +20.2% | 0.01% | 0.0% |
Q4 2014 | $19,336,000 | +20.6% | 473,113 | -0.1% | 0.01% | +16.7% |
Q3 2014 | $16,038,000 | -44.1% | 473,355 | -44.3% | 0.01% | -45.5% |
Q2 2014 | $28,668,000 | -39.6% | 850,445 | -32.1% | 0.01% | -42.1% |
Q1 2014 | $47,480,000 | +9.1% | 1,252,426 | -16.0% | 0.02% | +11.8% |
Q4 2013 | $43,530,000 | -14.9% | 1,490,764 | -0.3% | 0.02% | -22.7% |
Q3 2013 | $51,146,000 | +6.0% | 1,495,489 | +2.3% | 0.02% | 0.0% |
Q2 2013 | $48,234,000 | – | 1,462,073 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 5,491,035 | $85,550,000 | 2.90% |
PFM Health Sciences, LP | 1,108,659 | $17,273,000 | 0.46% |
Spark Investment Management LLC | 409,300 | $6,376,000 | 0.44% |
Partner Investment Management, L.P. | 13,101 | $204,000 | 0.26% |
DLD Asset Management, LP | 219,700 | $3,421,000 | 0.23% |
Bowling Portfolio Management LLC | 84,495 | $1,316,000 | 0.23% |
Matarin Capital Management, LLC | 136,020 | $2,119,192,000 | 0.17% |
Telemetry Investments, L.L.C. | 15,000 | $234,000 | 0.15% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 482,149 | $7,512,000 | 0.13% |
ALGERT GLOBAL LLC | 29,892 | $466,000 | 0.13% |